Ovarian Cancer Stage 3
Oncology
Prevalence
24.0 / 100K
Incidence
10.6 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Ovarian Cancer Stage 3?
There are 2 clinical trials targeting Ovarian Cancer Stage 3 tracked by BioSniper.
What is the prevalence of Ovarian Cancer Stage 3?
The estimated prevalence of Ovarian Cancer Stage 3 is approximately 24.0 per 100,000 population.
Deep-dive into Ovarian Cancer Stage 3
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis